Massachusetts · 91304

Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in Massachusetts

Massachusetts Medicare Avg
$145.24
2% above national avg
National Medicare Avg
$142.52
All states combined
Billed Charge (MA)
$155.50
What providers submit
Est. Commercial (MA)
$377.62
National avg: $319.25
Est. Cash / Self-Pay (MA)
$151.69
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

401
Services in MA
148
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Massachusetts

Provider Medicare Services
Costco Wholesale Corporation $145.24 28
Costco Wholesale Corporation $145.24 27
Costco Wholesale Corporation $145.24 24

Massachusetts Pricing in Context

In Massachusetts, CPT code 91304 (Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use) carries an average Medicare payment of $145.24 — 2% above the national benchmark of $142.52. 148 providers across the state submitted claims for this procedure in 2023, performing 401 total services. Individual payments in MA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Massachusetts is $155.50, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Massachusetts sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Massachusetts lands near $377.62, with self-pay cash prices typically around $151.69. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cost in Massachusetts?

The average Medicare payment for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in Massachusetts is $145.24, which is 2% above the national average of $142.52. Providers in MA typically bill $155.50 for this procedure.

What does Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cost with insurance in Massachusetts?

With commercial insurance in Massachusetts, Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use costs an estimated $377.62. Without insurance, the estimated cash price is $151.69. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in Massachusetts?

148 providers in Massachusetts billed Medicare for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use in 2023, performing 401 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use cheaper in Massachusetts than the national average?

No — Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Recombinant Spike Protein Nanoparticle, Saponin-Based Adjuvant, Preservative Free, 5 Mcg/0.5ml Dosage, For Intramuscular Use costs 2% above the national average in Massachusetts. The state average Medicare payment is $145.24 compared to $142.52 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial